跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16 条关于
“Elragllusib”
全部
16
临床试验
2
药物
1
机构
0
资讯
13
去年
Lantern Pharma Highlights AI-Driven Oncology Drug Development in Upcoming Webinars
去年
Elraglusib Receives FDA Rare Pediatric Disease Designation for Ewing Sarcoma
去年
Elraglusib Plus Chemotherapy Shows Promise in Metastatic Pancreatic Cancer
2年前
Elraglusib Receives FDA Orphan Drug Designation for Soft Tissue Sarcoma
去年
Elraglusib Granted FDA Rare Pediatric Disease Designation for Ewing Sarcoma
去年
Elraglusib Granted FDA Rare Pediatric Disease Designation for Ewing Sarcoma
3年前
Elraglusib Receives FDA Orphan Drug Designation for Pancreatic Cancer Treatment
去年
Elraglusib Receives EMA Orphan Drug Designation for Pancreatic Cancer Treatment
去年
Elraglusib Shows Promise for Advanced Salivary Gland Carcinoma in Upcoming AACR Presentation
2年前
Actuate Therapeutics' Elraglusib Shows Promise in Relapsed/Refractory Ewing Sarcoma Trial
第 1 页,共 2 页
上一页
下一页